NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-OD-17-027 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-CA-17-005 from the NIH Guide for Grants and Contracts. This National Cancer Institute (NCI) funding opportunity announcement (FOA) solicits applications for multidisciplinary Cancer Immune Monitoring and Analysis Centers (CIMACs) that will serve as the main units of the Network for correlative studies in clinical trials involving immunotherapy. The Network will encompass two to three CIMACs (to be supported by this FOA) and a single Cancer Immunologic Data Commons (CIDC) (to be supported by the companion FOA, RFA-CA-17-006) forming a CIMACs-CIDC Network.
Funding Opportunity RFA-CA-17-006 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications for establishment of a Cancer Immunologic Data Commons (CIDC) to provide bioinformatics support as part of a Network for correlative studies in clinical trials involving cancer immunotherapy. The Network will encompass a single CIDC award (to be supported by this FOA) and up to three Cancer Immune Monitoring and Analysis Centers (CIMACs) (to be supported by a companion FOA, RFA-CA-17-005).
Funding Opportunity RFA-CA-17-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support canine clinical studies using immunotherapeutic agents and novel drug combinations (such as immune modulators, molecular targeted agents, chemotherapy, and/or radiation) together with laboratory correlative studies that seek to describe characterize and understand the cellular and molecular mechanisms that determine the anti-tumor response (or non-response) in dogs with spontaneous tumors. The FOA will support a network of laboratories and canine clinical trial sites. A companion funding opportunity (see U24 funding opportunity RFA-CA-17-002) will support a coordinating center that will aid in the development, standardization, and conduct of the clinical and laboratory studies as well as data management across the funded U01 sites.
Funding Opportunity RFA-CA-17-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support a coordinating center for a network of cooperative agreements (see U01 FOA RFA-CA-17-001) that will conduct clinical trials in pet dogs with spontaneous tumors and perform laboratory correlative studies associated with the clinical trials. This FOA will work with the NCI Comparative Oncology Program (COP) of the NCI's Center for Cancer Research as an integral component and will provide statistical support; assist with the development and standardization of clinical protocols and laboratory immune monitoring assays; assist with the implementation of clinical studies in immunotherapy and combination agents including accrual to the trials; manage clinical and correlative data from all U01 sites and their collaborators including immune-related adverse events; facilitate the sharing of agents, specimens, and data; and create an ad hoc steering committee of required expertise--both inside and outside the U01 network, including the PD/PIs of the U01s, representatives of the COP and the NCI Program Official--to ensure that the goals of the network are accomplished.
Funding Opportunity RFA-CA-17-015 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate research in the area of PDAC microenvironment with the ultimate goal of understanding the interaction between tumors and the microenvironment. The plan is to design new immunotherapy and combination interventions that would accommodate and build on the distinct characteristics of this interaction. It is expected that the interventions will lead to improved responses in pre-clinical models and clinical evaluation either in NCI-based early phase networks (ETCTN), or by industry or cancer centers.
Funding Opportunity RFA-CA-17-016 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications to establish a Resource Center (RC) for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (Consortium) that has the ultimate goal to design new immunotherapy and combination interventions in PDAC.
Funding Opportunity PA-17-089 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites studies employing secondary analysis of existing cohorts, data sets and biorepositories to explore clinically related issues on aging changes influencing health across the lifespan, including diseases and disabilities in older persons. Use of cohorts that are linked to electronic health record systems and/or Centers for Medicare and Medicaid Services (CMS) administrative data are especially welcome. This FOA will support exploratory analysis of innovative hypotheses in clinical aging research and/or to inform design of future epidemiologic or human intervention studies. Costs related to data harmonization, archival activities and/or assay refinement may be included in the budget, as long as they are pertinent to the specific aims of the proposed project.
Funding Opportunity PA-17-088 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications employing secondary analysis of existing data sets or stored biospecimens, to address clinically related issues on aging changes influencing health across the lifespan, and/or on diseases and disabilities in older persons. Use of cohorts that are linked to electronic health record systems and/or Centers for Medicare and Medicaid Services (CMS) administrative data are especially welcome. This FOA will support activities addressing specific hypotheses in clinical aging research and/or to inform the design and implementation of future epidemiologic or human intervention studies, or current geriatric practice in maintenance of health, management of disease, and prevention of disability. Existing data sets may also be used to develop and test new statistical analytical approaches. Costs for archiving of data to be made publicly available and those associated with data harmonization or assay refinement/validation may be included in the budget, as long as these activities are pertinent to the proposed secondary analyses.
Funding Opportunity PA-17-090 from the NIH Guide for Grants and Contracts. The National Library of Medicine, in conjunction with NIH Institutes and Centers (ICs) named above, announces an Administrative Supplement opportunity available to eligible NIH awardees with active R01 grants and, in some cases, with the other active awards with the activity codes listed above. (see IC-specific details in the Activity Code section above).
Funding Opportunity RFA-HD-18-017 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage integrated and synergistic research in the study of uterine fibroids, endometriosis, adenomyosis, or gynecologic pain syndromes.
Funding Opportunity PAR-17-087 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage research focused on tobacco use and human immunodeficiency virus (HIV) infection in low and middle income countries (LMICs). In particular, applications are encouraged that focus on the development and evaluation of tobacco cessation interventions tailored to HIV positive populations, including those with co-morbidities such as tuberculosis (TB), in low-resource settings in LMICs. This FOA provides funding for research planning, intervention delivery, and follow-up activities.
Funding Opportunity PAR-17-086 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage exploratory/developmental research focused on tobacco use and human immunodeficiency virus (HIV) infection in low and middle income countries (LMICs). In particular, applications are encouraged that focus on the development and evaluation of tobacco cessation interventions tailored to HIV positive populations, including those with co-morbidities such as tuberculosis (TB), in low-resource settings in LMICs. This FOA provides funding for research planning, intervention delivery, and follow-up activities.
Funding Opportunity RFA-OH-17-001 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to enhance the quality and availability of health and safety training for mine workers in the Western United States. As a result, the National Institute for Occupational Safety and Health (NIOSH) invites applications for cooperative agreements to support the development and implementation of training and education programs.
Notice NOT-HD-16-038 from the NIH Guide for Grants and Contracts
Notice NOT-DA-17-006 from the NIH Guide for Grants and Contracts
Notice NOT-HD-16-039 from the NIH Guide for Grants and Contracts
Notice NOT-HD-16-037 from the NIH Guide for Grants and Contracts
Notice NOT-CA-17-006 from the NIH Guide for Grants and Contracts
Notice NOT-AG-16-083 from the NIH Guide for Grants and Contracts